State Street’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
418,984
+4,996
| +1% | +$47.8K | ﹤0.01% | 3037 |
|
|
2025
Q1 | $3.85M | Buy |
413,988
+6,415
| +2% | +$59.7K | ﹤0.01% | 2983 |
|
|
2024
Q4 | $5.67M | Buy |
407,573
+22,841
| +6% | +$317K | ﹤0.01% | 2913 |
|
|
2024
Q3 | $9.05M | Buy |
384,732
+16,248
| +4% | +$382K | ﹤0.01% | 2667 |
|
|
2024
Q2 | $5.89M | Buy |
368,484
+76,250
| +26% | +$1.22M | ﹤0.01% | 2846 |
|
|
2024
Q1 | $4.79M | Buy |
292,234
+26,880
| +10% | +$441K | ﹤0.01% | 2940 |
|
|
2023
Q4 | $3.68M | Buy |
265,354
+5,896
| +2% | +$81.7K | ﹤0.01% | 3091 |
|
|
2023
Q3 | $3.57M | Buy |
259,458
+3,081
| +1% | +$42.4K | ﹤0.01% | 3084 |
|
|
2023
Q2 | $4.37M | Buy |
256,377
+24,288
| +10% | +$414K | ﹤0.01% | 3059 |
|
|
2023
Q1 | $3.73M | Buy |
232,089
+15,463
| +7% | +$248K | ﹤0.01% | 3102 |
|
|
2022
Q4 | $1.65M | Sell |
216,626
-1,362
| -0.6% | -$10.4K | ﹤0.01% | 3435 |
|
|
2022
Q3 | $1.92M | Buy |
217,988
+3,963
| +2% | +$34.8K | ﹤0.01% | 3426 |
|
|
2022
Q2 | $1.53M | Buy |
214,025
+10,345
| +5% | +$74K | ﹤0.01% | 3539 |
|
|
2022
Q1 | $2.18M | Buy |
203,680
+72,670
| +55% | +$777K | ﹤0.01% | 3533 |
|
|
2021
Q4 | $1.84M | Buy |
+131,010
| New | +$1.84M | ﹤0.01% | 3662 |
|